Record Display for the EPA National Library Catalog

RECORD NUMBER: 5 OF 2109

OLS Field Name OLS Field Data
Main Title 1,3-dichloro-2-propanol: 13-week Gavage Toxicity Study in Sprague-dawley Rats (Final Report) with Cover Letter.
CORP Author Dow Chemical Co., Midland, MI.; Environmental Protection Agency, Washington, DC. Office of Toxic Substances.
Year Published 1989
Report Number 40-8915319
Stock Number OTS0526377
Additional Subjects Toxicology ; Health effects ; 1 ; 3-dichloro-2-propanol ; Subchronic Toxicity ; Mammals ; Rats ; Oral ; Gavage ; Toxic substances ; Laboratory animals ; CAS No 96-23-1
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  OTS0526377 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 03/10/2010
Collation 79p
Abstract
1,3-Dichloro-2-propanol (DCP) was evaluated for subchronic toxicity in Sprague-Dawley rats (10/sex/dose group) administered dose levels of 0, 0.1, 1, 10, or 100 mg DCP/kg bw/day by gavage in distilled water 5 days/week for 13 weeks. No adverse clinical signs were observed during the study in any dose group. Final body weight gain was 8% lower in high-dose males than in control rats. Sporadic decreases in food consumption were observed in high-dose males and females. Exposure to 100 mg/kg DCP induced a statistically significant decrease in hemoglobin and hematocrit in both sexes. High-dose females showed a significant increasein urinary proteins, but this effect was not observed in males. Numerous clinical chemistry effects detected were a reflection of liver damage in high-dose males and females and of kidney damage in high-dose females. Absolute and relative liver and kidney weights were significantly increased in high-dose groups. Gross pathology effects attributed to DCP-treatment were limited to gastric irritation in the 10 and 100 mg/kg groups. Histopathological alterations due to treatment with DCP were confined to the stomach, liver, and kidney of rats given 10 and 100 mg/kg, and to the nasal tissues of rats in the high-dose groups. The 1 mg/kg dose was the no-adverse-effect level.